文献速递牙周病

白细胞介素-17通过NRF2与p-STAT3相互作用抑制铁死亡减轻牙槽骨丢失

Interleukin-17 alleviates erastin-induced alveolar bone loss by suppressing ferroptosis via interaction between NRF2 and p-STAT3.
PubMed 文献 · J Clin Periodontol · 2023-11-14

该研究探讨白细胞介素-17(IL-17)与铁死亡及成骨分化的关系。在实验性牙周炎模型中分析铁死亡相关分子变化,并在动物模型和原代小鼠下颌骨成骨细胞中研究erastin和IL-17对牙槽骨丢失与修复的影响。结果显示IL-17可减轻erastin加重的牙槽骨丢失,并逆转erastin抑制的成骨分化,机制可能涉及p-STAT3与NRF2在核内的物理相互作用。

要点

  • IL-17可减轻erastin加重的实验性牙周炎牙槽骨丢失。
  • IL-17通过逆转铁死亡改善erastin抑制的成骨分化。
  • p-STAT3与NRF2在核内相互作用参与下游转录调控。

核心结论

  • IL-17给药可抵抗erastin诱导的成骨细胞铁死亡和成骨抑制。
  • 其可能机制涉及p-STAT3直接与NRF2相互作用。

研究设计与样本

  • 研究分析实验性牙周炎模型中铁死亡相关分子变化。
  • 在动物模型中研究erastin和IL-17对牙槽骨丢失与修复的影响。
  • 体外使用原代小鼠下颌骨成骨细胞暴露于erastin和IL-17。
  • 采用siRNA、免疫荧光共定位和免疫沉淀确认NRF2、p-STAT3及其相互作用。

主要发现

  • 结扎组织中NRF2、谷胱甘肽过氧化物酶4和溶质载体家族7成员11水平低于正常牙周组织。
  • 在体内实验性牙周炎模型中,erastin加重牙槽骨丢失,IL-17减轻牙槽骨丢失。
  • 体外IL-17通过逆转铁死亡改善erastin抑制的成骨分化。
  • NRF2表达改变与铁死亡相关分子和成骨变化相关。
  • 在IL-17+erastin刺激的成骨细胞中,p-STAT3-NRF2复合物可能参与铁死亡和成骨相关基因的下游转录。

临床怎么用

  • 为牙周炎中IL-17调控铁死亡与成骨提供机制线索。
  • 提示NRF2-p-STAT3相互作用可能作为牙槽骨修复的潜在干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To investigate the relationship between interleukin-17 (IL-17), ferroptosis and osteogenic differentiation. MATERIALS AND METHODS: We first analysed the changes in ferroptosis-related molecules in experimental periodontitis models. The effects of erastin, a small-molecule ferroptosis inducer, and IL-17 on alveolar bone loss and repair in animal models were then investigated. Primary mouse mandibular osteoblasts were exposed to erastin and IL-17 in vitro. Ferroptosis- and osteogenesis-related genes and proteins were detected. Further, siRNA, immunofluorescence co-localization and immunoprecipitation were used to confirm the roles of the nuclear factor erythroid-2-related factor 2 (NRF2) and phosphorylated signal transducer and activator of transcription 3 (p-STAT3), as well as their interaction. RESULTS: The levels of NRF2, glutathione peroxidase 4 and solute carrier family 7 member 11 were lower in the ligated tissues than in normal periodontal tissues. Alveolar bone loss in an in vivo experimental periodontitis model was aggravated by erastin and alleviated by IL-17. In vitro, IL-17 ameliorated erastin-inhibited osteogenic differentiation by reversing ferroptosis. Altered NRF2 expression correlated with changes in ferroptosis-related molecules and osteogenesis. Furthermore, the physical interaction between NRF2 and p-STAT3 was confirmed in the nucleus. In IL-17 + erastin-stimulated osteoblasts, the p-STAT3-NRF2 complex might actively participate in the downstream transcription of ferroptosis- and osteogenesis-related genes. CONCLUSIONS: IL-17 administration conferred resistance to erastin-induced osteoblast ferroptosis and osteogenesis. The possible mechanism may involve p-STAT3 directly interacting with NRF2.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Bao J, Wang Z, Yang Y, et al. Interleukin-17 alleviates erastin-induced alveolar bone loss by suppressing ferroptosis via interaction between NRF2 and p-STAT3. J Clin Periodontol. 2023. PMID: 37961757. doi:10.1111/jcpe.13898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。